Hepatitis B immunisation for adults with end-stage kidney disease

Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primary objectivesWe aim to evaluate the beneficial and harmful effects of: hepatitis B immunisation in people with end‐stage kidney disease. Secondary objectivesWe aim to evaluate the beneficial and harmful effects of: reinforced vaccination series (three doses plus one additional booster) versus traditional triple inoculations; and intradermal versus intramuscular hepatitis B vaccination, in people with end‐stage kidney disease.